Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose- transporter-protein syndrome

Jörg Klepper, Marcela Garcia-Alvarez, Kevin R. O'Driscoll, Michael K. Parides, Dong Wang, Yuan Yuan Ho, Darryl C. De Vivo

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Glucose transport into the brain is mediated by a facilitative glucose- transporter protein, GLUT-1.A GLUT-1 defect results in the Glucose- Transporter-Protein Syndrome (GTPS), characterized by infantile epilepsy, developmental delay, and acquired microcephaly. The diagnosis is currently based on clinical features, low to normal lactate levels and low glucose levels (hypoglycorrhachia) in the cerebrospinal fluid, and the demonstration of impaired GLUT-1 function in erythrocytes as described here. Blood samples were collected in sodium-heparin or citrate-phosphate-dextrose solution and uptake of 14C-labeled 3-O-Methyl-D-glucose (3OMG) into erythrocytes (0.5 mmol/L 3OMG; 1μCi/mL) was measured at 4C and pH 7.4. Three-OMG influx was terminated at 5-second intervals, washed cells were lysed, and uptake was quantitated by liquid scintillation counting. Patients' uptake (n = 22) was 44 ± 8% of controls (100 ± 22%, n = 70). Statistical analyses showed an uptake cut-off point at 60% uptake, a sensitivity of 86% (95%-confidence interval 78 to 94%), and a specificity of 97% (95%-confidence interval 93 to 100%). Gender, age, and ketosis did not influence 3OMG uptake. This assay provides a reproducible and accurate laboratory test for diagnosing the GTPS.

Original languageEnglish (US)
Pages (from-to)116-121
Number of pages6
JournalJournal of Clinical Laboratory Analysis
Volume13
Issue number3
DOIs
StatePublished - May 12 1999
Externally publishedYes

Fingerprint

3-O-Methylglucose
Facilitative Glucose Transport Proteins
Assays
Erythrocytes
Glucose Transporter Type 1
Confidence Intervals
Cerebrospinal fluid
Glucose
Scintillation Counting
Microcephaly
Ketosis
Proteins
Scintillation
Cerebrospinal Fluid
Heparin
Epilepsy
Lactic Acid
Brain
Blood
Demonstrations

Keywords

  • 3-O-methyl-D- glucose
  • 3OMG-glucose transport
  • Blood- brain barrier
  • De Vivo disease
  • Erythrocyte
  • Glucose transporter
  • Glucose-transporter-protein syndrome
  • GLUT-1
  • GTPS
  • Infantile seizures

ASJC Scopus subject areas

  • Immunology and Allergy
  • Hematology
  • Public Health, Environmental and Occupational Health
  • Clinical Biochemistry
  • Medical Laboratory Technology
  • Biochemistry, medical
  • Microbiology (medical)

Cite this

Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose- transporter-protein syndrome. / Klepper, Jörg; Garcia-Alvarez, Marcela; O'Driscoll, Kevin R.; Parides, Michael K.; Wang, Dong; Ho, Yuan Yuan; De Vivo, Darryl C.

In: Journal of Clinical Laboratory Analysis, Vol. 13, No. 3, 12.05.1999, p. 116-121.

Research output: Contribution to journalArticle

Klepper, Jörg ; Garcia-Alvarez, Marcela ; O'Driscoll, Kevin R. ; Parides, Michael K. ; Wang, Dong ; Ho, Yuan Yuan ; De Vivo, Darryl C. / Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose- transporter-protein syndrome. In: Journal of Clinical Laboratory Analysis. 1999 ; Vol. 13, No. 3. pp. 116-121.
@article{c7c2db0da5564aeda18dbb5f5823f709,
title = "Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose- transporter-protein syndrome",
abstract = "Glucose transport into the brain is mediated by a facilitative glucose- transporter protein, GLUT-1.A GLUT-1 defect results in the Glucose- Transporter-Protein Syndrome (GTPS), characterized by infantile epilepsy, developmental delay, and acquired microcephaly. The diagnosis is currently based on clinical features, low to normal lactate levels and low glucose levels (hypoglycorrhachia) in the cerebrospinal fluid, and the demonstration of impaired GLUT-1 function in erythrocytes as described here. Blood samples were collected in sodium-heparin or citrate-phosphate-dextrose solution and uptake of 14C-labeled 3-O-Methyl-D-glucose (3OMG) into erythrocytes (0.5 mmol/L 3OMG; 1μCi/mL) was measured at 4C and pH 7.4. Three-OMG influx was terminated at 5-second intervals, washed cells were lysed, and uptake was quantitated by liquid scintillation counting. Patients' uptake (n = 22) was 44 ± 8{\%} of controls (100 ± 22{\%}, n = 70). Statistical analyses showed an uptake cut-off point at 60{\%} uptake, a sensitivity of 86{\%} (95{\%}-confidence interval 78 to 94{\%}), and a specificity of 97{\%} (95{\%}-confidence interval 93 to 100{\%}). Gender, age, and ketosis did not influence 3OMG uptake. This assay provides a reproducible and accurate laboratory test for diagnosing the GTPS.",
keywords = "3-O-methyl-D- glucose, 3OMG-glucose transport, Blood- brain barrier, De Vivo disease, Erythrocyte, Glucose transporter, Glucose-transporter-protein syndrome, GLUT-1, GTPS, Infantile seizures",
author = "J{\"o}rg Klepper and Marcela Garcia-Alvarez and O'Driscoll, {Kevin R.} and Parides, {Michael K.} and Dong Wang and Ho, {Yuan Yuan} and {De Vivo}, {Darryl C.}",
year = "1999",
month = "5",
day = "12",
doi = "10.1002/(SICI)1098-2825(1999)13:3<116::AID-JCLA5>3.0.CO;2-C",
language = "English (US)",
volume = "13",
pages = "116--121",
journal = "Journal of Clinical Laboratory Analysis",
issn = "0887-8013",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose- transporter-protein syndrome

AU - Klepper, Jörg

AU - Garcia-Alvarez, Marcela

AU - O'Driscoll, Kevin R.

AU - Parides, Michael K.

AU - Wang, Dong

AU - Ho, Yuan Yuan

AU - De Vivo, Darryl C.

PY - 1999/5/12

Y1 - 1999/5/12

N2 - Glucose transport into the brain is mediated by a facilitative glucose- transporter protein, GLUT-1.A GLUT-1 defect results in the Glucose- Transporter-Protein Syndrome (GTPS), characterized by infantile epilepsy, developmental delay, and acquired microcephaly. The diagnosis is currently based on clinical features, low to normal lactate levels and low glucose levels (hypoglycorrhachia) in the cerebrospinal fluid, and the demonstration of impaired GLUT-1 function in erythrocytes as described here. Blood samples were collected in sodium-heparin or citrate-phosphate-dextrose solution and uptake of 14C-labeled 3-O-Methyl-D-glucose (3OMG) into erythrocytes (0.5 mmol/L 3OMG; 1μCi/mL) was measured at 4C and pH 7.4. Three-OMG influx was terminated at 5-second intervals, washed cells were lysed, and uptake was quantitated by liquid scintillation counting. Patients' uptake (n = 22) was 44 ± 8% of controls (100 ± 22%, n = 70). Statistical analyses showed an uptake cut-off point at 60% uptake, a sensitivity of 86% (95%-confidence interval 78 to 94%), and a specificity of 97% (95%-confidence interval 93 to 100%). Gender, age, and ketosis did not influence 3OMG uptake. This assay provides a reproducible and accurate laboratory test for diagnosing the GTPS.

AB - Glucose transport into the brain is mediated by a facilitative glucose- transporter protein, GLUT-1.A GLUT-1 defect results in the Glucose- Transporter-Protein Syndrome (GTPS), characterized by infantile epilepsy, developmental delay, and acquired microcephaly. The diagnosis is currently based on clinical features, low to normal lactate levels and low glucose levels (hypoglycorrhachia) in the cerebrospinal fluid, and the demonstration of impaired GLUT-1 function in erythrocytes as described here. Blood samples were collected in sodium-heparin or citrate-phosphate-dextrose solution and uptake of 14C-labeled 3-O-Methyl-D-glucose (3OMG) into erythrocytes (0.5 mmol/L 3OMG; 1μCi/mL) was measured at 4C and pH 7.4. Three-OMG influx was terminated at 5-second intervals, washed cells were lysed, and uptake was quantitated by liquid scintillation counting. Patients' uptake (n = 22) was 44 ± 8% of controls (100 ± 22%, n = 70). Statistical analyses showed an uptake cut-off point at 60% uptake, a sensitivity of 86% (95%-confidence interval 78 to 94%), and a specificity of 97% (95%-confidence interval 93 to 100%). Gender, age, and ketosis did not influence 3OMG uptake. This assay provides a reproducible and accurate laboratory test for diagnosing the GTPS.

KW - 3-O-methyl-D- glucose

KW - 3OMG-glucose transport

KW - Blood- brain barrier

KW - De Vivo disease

KW - Erythrocyte

KW - Glucose transporter

KW - Glucose-transporter-protein syndrome

KW - GLUT-1

KW - GTPS

KW - Infantile seizures

UR - http://www.scopus.com/inward/record.url?scp=0032946375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032946375&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2825(1999)13:3<116::AID-JCLA5>3.0.CO;2-C

DO - 10.1002/(SICI)1098-2825(1999)13:3<116::AID-JCLA5>3.0.CO;2-C

M3 - Article

C2 - 10323476

AN - SCOPUS:0032946375

VL - 13

SP - 116

EP - 121

JO - Journal of Clinical Laboratory Analysis

JF - Journal of Clinical Laboratory Analysis

SN - 0887-8013

IS - 3

ER -